Pender Fund Capital Management Ltd. Chembio Diagnostics, Inc. Transaction History

Pender Fund Capital Management Ltd.

  • $117 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.25 - $0.45 $36,864 - $66,356
147,459 New
147,459 $88,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Pender Fund Capital Management Ltd. Portfolio

Follow Pender Fund Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pender Fund Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pender Fund Capital Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email